Tetsuya Okano
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Comparative Treatment Outcomes Across Actionable Genomic Alterations in NSCLC: A Large Multicenter Real-World Study.
Journal: JTO clinical and research reports
Published: February 12, 2026
Effect of type 2 diabetes mellitus on systemic treatment for advanced non-small cell lung cancer.
Journal: Translational lung cancer research
Published: March 15, 2025
Plasma biomarkers for afatinib monotherapy in EGFR-mutated non-small cell lung cancer: Novel insights from companion genomics analysis of the EXTRA study.
Journal: Cancer treatment and research communications
Published: October 15, 2024
Optimal dose of maintenance steroid therapy for relapse of chronic eosinophilic pneumonia: a multicentre retrospective study.
Journal: BMJ open respiratory research
Published: September 25, 2024
Venous thromboembolism in patients undergoing surgery for lung cancer: a post hoc analysis of the Cancer-VTE Registry.
Journal: Japanese journal of clinical oncology
Published: March 24, 2024
Improvement in idiopathic interstitial pneumonia by adding macitentan to a patient unresponsive to nintedanib.
Journal: Respiratory medicine case reports
Published: February 20, 2024
Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 10, 2024
Clinical course of COPD patients with exercise-induced elevation of pulmonary artery pressure or less severe pulmonary hypertension presenting with respiratory symptoms and the impact of bosentan intervention-prospective, single-center, randomized, parallel-group study.
Journal: BMC pulmonary medicine
Published: June 10, 2023
Successful immunosuppressant-free treatment of a drug-induced sarcoidosis-like reaction caused by dupilumab.
Journal: Respiratory medicine case reports
Published: April 16, 2023
A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small Cell Lung Cancer Study: (NEJ048A/NEXUS).
Journal: Clinical lung cancer
Published: December 06, 2022
One-Year Incidences of Venous Thromboembolism, Bleeding, and Death in Patients With Lung Cancer (Cancer-VTE Subanalysis).
Journal: JTO clinical and research reports
Published: May 30, 2022
Last Updated: 09/26/2026